Universal Health Services Inc (UHS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Universal Health Services Inc   (NYSE: UHS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Universal Health Services Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Universal Health Services Inc 's ROA in the second quarter of 2026?
Universal Health Services Inc achieved a return on average assets (ROA) of 7.79 % in its second quarter of 2026, this is above UHS's average return on assets of 7.09%.
Universal Health Services Inc s assets during the 12 months ending in the second quarter of 2026 are valued at $19 billion

ROA fell compared to the first quarter of 2026, despite the net income growth of 1.65% from the first quarter of 2026.

However, within the Healthcare sector 98 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 606, from total ROA ranking in the first quarter of 2026 at 709.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 47.27 % 8.39 % 56.62 % 46.2 % 6.97 %
Y / Y Net Income Change 0.55 % 11.52 % 32.87 % 42.57 % 23.2 %
Net Income (TTM) in million 1,550 1,548 1,511 1,400 1,287
Return On Assets (TTM) 7.79 % 8.52 % 8.46 % 8.82 % 9.02 %
UHS's Total Ranking # 606 # 709 # 655 # 714 # 749
Total Assets (TTM) in million 21,501 15,681 22,009 20,373 14,599
Seq. Total Assets Change 37.12 % -28.75 % 8.03 % 39.55 % 0.91 %
Seq. Net Income Change 1.65 % -19.91 % 18.13 % 4.55 % 12.74 %



Return On Assets Company Ranking
Within: No.
Industry # 6
Sector # 99
Overall # 607

Return On Assets Statistics
High Average Low
10.06 %
7.09 %
4.9 %
(Mar 31 2026)   (Sep 30 2023)





Financial Statements
Universal Health Services Inc 's Assets $ 21,501 million UHS's Balance sheet
Universal Health Services Inc 's Income $ 365 million Quarterly UHS's Income Statement
UHS's Income by Division See UHS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 10.49 % 3.82 % 3.79 % 2.46 % -3.16 %
Total Assets in million 15,528 14,053 13,536 13,042 12,728
Y / Y Net Income Change 29.93 % 61.7 % 9.49 % -33.48 % 3.66 %
Net Income in million 1,511 1,163 719 657 988
Annual Return On Assets 9.73 % 8.28 % 5.31 % 5.04 % 7.76 %




Comment on UHS's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 9.73 % compared to prior year, due to annual net income growth of 29.93 % to $1,511.18 million, while value of Universal Health Services Inc 's overall assets grew just by 10.49 % to $15,527.59 million, compared to $15,527.59 a year before.


More Return On Assets Ratios
UHS's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
UHS's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for UHS's Competitors
Subscribers only: Roa for Universal Health Services Inc 's Suppliers
Subscribers only: Return On Assets for UHS's Customers

You may also want to know
UHS's Roi UHS's Inventory Turnover Ratio UHS's Growth Rates UHS's Dividend Comparisons
UHS's Profitability Ratios UHS's Asset Turnover Ratio UHS's Dividend Growth
UHS's Roe UHS's Valuation Ratios UHS's Financial Strength Ratios UHS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %
Dexcom Inc   14.87 %
Neurocrine Biosciences Inc   14.73 %
Entera Bio Ltd   14.60 %
Standard Biotools Inc   14.31 %
Arcutis Biotherapeutics Inc   14.23 %
Harmony Biosciences Holdings inc   14.15 %
Biolife Solutions Inc   14.09 %
Aveanna Healthcare Holdings Inc   13.82 %
West Pharmaceutical Services Inc   13.64 %
Medinotec Inc   13.38 %
Puma Biotechnology Inc   13.28 %
Sbc Medical Group Holdings Incorporated  13.26 %
Alpha Pro Tech Ltd   13.17 %


Date modified: 2026-09-12T06:14:28+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.